HB 2167 Virginia House of Delegates · 2017 Regular Session

Opioids and buprenorphine; Boards of Dentistry and Medicine to adopt regulations for prescribing.

Summary

Directs the Boards of Dentistry and Medicine to adopt regulations for the prescribing of opioids and products containing buprenorphine. The bill requires the Prescription Monitoring Program at the Department of Health Professions to provide an annual report to the Joint Commission on Health Care on the prescribing of opioids and benzodiazepines in the Commonwealth. The bill contains an emergency clause.

Bill status signed all 5 stages cleared

Introduction

Jan 2017

Committee Review

Feb 2017

House of Delegates Passage

Jan 2017

Senate Passage

Jan 2017

Signed into Law

Mar 2017

Introduced Jan 11, 2017 Signed Mar 3, 2017

Floor votes

How they voted

This bill passed the Senate by voice vote (no roll call recorded).

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Amendments

Mar 3, 2017

Signed into law

Approved by Governor-Chapter 291 (effective 3/3/17)

executive

Feb 15, 2017

Introduced

Senate amendment agreed to by House (97-Y 0-N)

legislature

Feb 13, 2017

Introduced

Engrossed by Senate as amended

legislature

Feb 13, 2017

Legislature · Passed

Committee amendment agreed to

legislature

Feb 13, 2017

Introduced

Reading of amendment waived

legislature

Feb 1, 2017

Committee

Referred to Committee on Education and Health

legislature

Jan 31, 2017

Legislature · Passed

Read third time and passed House BLOCK VOTE (97-Y 0-N)

legislature

Jan 17, 2017

Committee

Assigned HWI sub: Subcommittee #1

legislature

Jan 11, 2017

Committee

Referred to Committee on Health, Welfare and Institutions

legislature

Jan 11, 2017

Introduced

Prefiled and ordered printed with emergency clause; offered 01/13/16 17103362D

legislature

1 primary · 7 co-sponsors